Acurex Biosciences vs mbiomics
Acurex Biosciences vs mbiomics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Acurex Biosciences is on 34/100 and mbiomics on 48/100.
Where each one leads
Acurex Biosciences
Leads on none of the measures we hold for both companies.
mbiomics
- our overall score: 48/100 against 34/100
- funding raised: $12.0M against $1.0M
At a glance
| Measure | Acurex Biosciences | mbiomics |
|---|---|---|
| What it is | Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders. | Advancing scalable microbiome-based therapeutics for severe and chronic diseases. |
| Category | Biotechnology, Pharmaceuticals, Neuroscience, Healthcare | Biotechnology, Pharmaceuticals, Healthcare, Artificial Intelligence |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2019 | 2020 |
| Headquarters | San Carlos, USA | Munich, Germany |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Acurex Biosciences | mbiomics |
|---|---|---|
| Total funding | $1.0M | $12.0M |
| Latest round | Grant | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Acurex Biosciences | mbiomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 48/100 |
| Traction | 30/100 | 35/100 |
| Team | Not published | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 18/100 | 2/100 |
| Quality | 45/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (42/100) |
| Domain ratingLink authority, 0-100 | Not published | 9/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Acurex Biosciences | mbiomics |
|---|---|---|
| CMS | Not detected | Framer |
Acurex Biosciences vs mbiomics: common questions
Which is better, Acurex Biosciences or mbiomics?
On our 0-100 score mbiomics rates higher (48/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Acurex Biosciences and mbiomics compare on the numbers?
mbiomics leads on our overall score (48/100 against 34/100), funding raised ($12.0M against $1.0M).
Read the full Acurex Biosciences review and pricing or the mbiomics review and pricing. You can also browse other Acurex Biosciences alternatives we track.